FingerprintDive into the research topics of 'Which factors predict bowel complications in patients with recurrent epithelial ovarian cancer being treated with bevacizumab?'. Together they form a unique fingerprint.
- Sort by
D. L. Richardson, F. J. Backes, J. D. Hurt, L. G. Seamon, L. J. Copeland, J. M. Fowler, D. E. Cohn, D. M. O'Malley
Research output: Contribution to journal › Article › peer-review